Header Logo

Connection

Naoko Takebe to Guanosine Triphosphate

Back to Details
This is a "connection" page, showing publications Naoko Takebe has written about Guanosine Triphosphate.
Naoko Takebe
Connection Strength
0.061
Guanosine Triphosphate
  1. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients. Clin Cancer Res. 2004 Dec 15; 10(24):8301-8.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.